2018 American Transplant Congress
Laparoscopic Donor Nephrectomy – The BMI Effect
Aims: To evaluate the outcomes of Laparoscopic Donor Nephrectomy (LDN) across 4 BMI groups.Methods : Using the SRTR database, all LDNs performed between 2006-2015 were…2018 American Transplant Congress
Robotic Pancreas Transplantation in Obese Recipients: Preliminary Results
1Surgery, University of Illinois, Chicago, IL; 2Surgery, University of Virginia, Virginia, VA.
IntroductionObesity is considered a relative contraindication to pancreas transplantation due to increased risks of wound and surgical related complications. Robotic surgery has never been applied…2018 American Transplant Congress
Differences in Rejection and Clinical Outcomes in Obese versus Non-Obese Renal Transplant Recipients Receiving Basiliximab Induction Immunosuppression
Introduction: Basilixiab is a fixed-dose IL-2 receptor antagonist that is used for non-lymphodepleting induction therapy. The impact of obesity on basiliximab pharmacokinetics and pharmacodynamics is…2018 American Transplant Congress
Weight Changes before and after Kidney Donation
IntroductionLiving kidney donors remain at low risk of end stage kidney disease but obese and overweight donors' risk is increased. We aimed to describe the…2018 American Transplant Congress
Pre-Donation Body Mass Index Associations with Outcomes in Living Kidney Donors: A Single Centre Experience
West London Renal and Transplant Centre, Imperial College NHS Trust, London, United Kingdom.
Background. Living kidney donor (LD) eligibility criteria have expanded as a result of excellent donor outcomes and increasing organ demand. However, considerable variability exists between…2018 American Transplant Congress
Adjusted Body Weight Dosing of Rabbit Antithymocyte Globulin in Obese Renal Transplant Recipients Preserves Excellent Clinical Outcomes at 3 Years and Improves the Value of Care
University of Virginia Health System, Charlottesville, VA.
There is significant variability in antithymocyte globulin (ATG) dosing practices among centers. In the obese population, use of total body weight (TBW) vs. adjusted body…2017 American Transplant Congress
Long-Term Follow-Up of the Safety and Effects of Bariatric Surgery on Immunosuppression in Post-Transplant Patients.
Objectives: To report the safety and feasibility of maintaining immunosuppression and graft safety after bariatric surgery among solid organ transplanted patients.Summary Background Data: Transplanted patients…2017 American Transplant Congress
Bariatric Operations at a Service of the Transplant Surgery.
IntroductionInvolvement of bariatric operations in the peri-transplant setting could be at different stages – prospective living organ donor (group 1), prospective organ recipient (2), patients…2017 American Transplant Congress
Barriers to Becoming Active on the Renal Transplant Waiting List: Have They Changed in the Last Five Years?
PURPOSEWe have previously studied the barriers preventing patients from being made active on the transplant waiting list (TWL) and implemented practice changes to improve the…2017 American Transplant Congress
Can We Successfully Overcome Obesity as a Barrier for Kidney Transplantation?
Obesity is a significant barrier for kidney transplantation (KT) with higher rates of denial for listing and longer listing to transplantation interval. We examined the…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 24
- Next Page »